Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026

Bulletin Express

Mar 20

Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.

The company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.

Key management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.

Investors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.

Further details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1111826406"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111826406\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111826406?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111826406","market":"hk","top_or_hot":-1,"title":"Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.</p>\n<p>The company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.</p>\n<p>Key management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.</p>\n<p>Investors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.</p>\n<p>Further details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-20 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.</p>\n<p>The company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.</p>\n<p>Key management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.</p>\n<p>Investors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.</p>\n<p>Further details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1111826406","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111826406","pubTimestamp":1774002196,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物(01877/688180)定于2026年3月27日举行2025年度业绩说明会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (stock code: 01877 HK; 688180 SH) will host its 2025 annual results briefing on 27 March 2026 from 10:00 to 11:00 (Beijing time). The session will be conducted via the Shanghai Stock Exchange (SSE) Roadshow Center’s online interaction platform.\nThe company released its 2025 annual report on 14 March 2026 and organised the briefing to give investors a comprehensive update on operating results and financial position. Management will address matters of broad investor interest and respond to pre-submitted questions.\nKey management participants include Executive Director, General Manager and CEO Zou Jianjun; Independent Non-Executive Director Zhang Chun; Financial Director Xu Baohong; and Board Secretary Wang Zhengyu.\nInvestors can submit questions in advance through the “Pre-collection of Questions” section on the SSE Roadshow Center homepage or via email (info@junshipharma.com) until 16:00 on 26 March 2026. Real-time interaction will be available during the briefing through the same online platform.\nFurther details, including a post-event summary, will be accessible on the SSE Roadshow Center website following the event.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}